14.72EUR0.00%Mkt Cap: 423.79M EURP/E: 34.62Last update: 2026-05-14
Ion Beam Applications SA designs, produces, and markets solutions for cancer diagnosis and treatments in Belgium, the United States, and internationally. It operates through Proton Therapy and Other Accelerators; and Dos…
Industry Peers
Medical Devicesloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)34.62
P/E (Forward)13.59
PEG—
P/B3.85
P/S0.68
EV/EBITDA11.98
EV/Revenue0.77
EPS (TTM)0.42
EPS (Forward)1.07
Cash Flow & Leverage
FCF Yield-5.85%
FCF Margin-4.00%
Operating CF-10.59M EUR
CapEx (TTM)7.42M EUR
Net Debt/EBITDA1.29
Net Debt51.64M EUR
Technical
SMA 5013.88 (+6.0%)
SMA 20012.76 (+15.4%)
Beta1.19
S&P 52W Chg24.23%
Avg Vol (30d)35.23K
Avg Vol (10d)29.38K
Technical Indicators
RSI (14)60.1
MACD0.2665
MACD Signal0.1713
MACD Hist.+0.0952
BB Upper15.33 EUR
BB Middle14.25 EUR
BB Lower13.17 EUR
BB Width15.17%
ATR (14)0.4437 EUR
Vol Ratio (20d)0.82x
52W Range
9.90080% of range15.90
52W High15.90 EUR
52W Low9.900 EUR
Profitability
Gross Margin32.19%
EBITDA Margin6.44%
Profit Margin2.05%
Oper. Margin8.79%
ROE10.69%
ROA3.32%
Revenue Growth12.30%
Earnings Growth-21.70%
Balance Sheet
Debt/Equity0.39
Current Ratio0.99
Quick Ratio0.63
Book Value/Sh3.780 EUR
Cash/Share2.221 EUR
Dividends
Fwd Div Rate0.2400 EUR
Trail. Div Rate0.2500 EUR
Div. Yield1.65%
5Y Avg Yield1.49%
Payout Ratio57.10%
Ex-Div DateJun 18, 2025
Pay Date—
Ownership
Shares Out.29.15M
Float19.58M
Insiders36.10%
Institutions22.92%
Analyst Consensus
Rating—
Target (Mean)15.75 EUR
Target Range12.00 EUR – 18.50 EUR
# Analysts4
Company
Market Cap423.79M EUR
Enterprise Value478.83M EUR
Revenue (TTM)620.17M EUR
Gross Profit199.62M EUR
Net Income (TTM)12.73M EUR
Revenue/Share21.15 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees2.3K
Last Price14.72 EUR
CountryBE
SectorHealthcare
IndustryMedical Devices
ISINBE0003766806